The Role of LncRNAs in the Protective Action of Tamoxifen on the Ovaries of Tumor-Bearing Rats Receiving Cyclophosphamide

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Dec 17

PMID 39684249

Authors

Sylwia Swigonska

Anna Nynca

Tomasz Molcan

Brian K Petroff

Renata E Ciereszko

Affiliations

Soon will be listed here.

Abstract

Infertility due to ovarian toxicity is a common side effect of cancer treatment in premenopausal women. Tamoxifen (TAM) is a selective estrogen receptor modulator that prevented radiation- and chemotherapy-induced ovarian failure in preclinical studies. In the current study, we examined the potential regulatory role of long noncoding RNAs (lncRNAs) in the mechanism of action of TAM in the ovaries of tumor-bearing rats receiving cyclophosphamide (CPA) as cancer therapy. We identified 166 lncRNAs, among which 49 were demonstrated to be differentially expressed (DELs) in the ovaries of rats receiving TAM and CPA compared to those receiving only CPA. A total of 24 DELs were upregulated and 25 downregulated by tamoxifen. The identified DELs shared the characteristics of noncoding RNAs described in other reproductive tissues. Eleven of the identified DELs displayed divergent modes of action, regulating target transcripts via both cis- and trans-acting pathways. Functional enrichment analysis revealed that, among target genes ascribed to the identified DELs, the majority were involved in apoptosis, cell adhesion, immune response, and ovarian aging. The presented data suggest that the molecular mechanisms behind tamoxifen's protective effects in the ovaries may involve lncRNA-dependent regulation of critical signaling pathways related to inhibition of follicular transition and ovarian aging, along with the suppression of apoptosis and regulation of cell adhesion. Employing a tumor-bearing animal model undergoing chemotherapy, which accurately reflects the conditions of mammary cancer, reinforces the obtained results. Given that tamoxifen remains a key player in the management and prevention of breast cancer, understanding its ovarian-specific actions in cancer patients is crucial and requires detailed functional studies to clarify the underlying molecular mechanisms.

References

Fu L, Xu Y, Li D, Dai X, Xu X, Zhang J . Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing. Gene. 2018; 657:19-29. DOI: 10.1016/j.gene.2018.03.002. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Zhou W, Zhang T, Lian Y, Zhang W, Yang M, Li Y . Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks. Reprod Biomed Online. 2022; 44(5):777-790. DOI: 10.1016/j.rbmo.2022.01.007. View

Ugai T, Sasamoto N, Lee H, Ando M, Song M, Tamimi R . Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022; 19(10):656-673. PMC: 9509459. DOI: 10.1038/s41571-022-00672-8. View

Slack F, Chinnaiyan A . The Role of Non-coding RNAs in Oncology. Cell. 2019; 179(5):1033-1055. PMC: 7347159. DOI: 10.1016/j.cell.2019.10.017. View

Hao X, Anastacio A, Liu K, Rodriguez-Wallberg K . Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review. Int J Mol Sci. 2019; 20(19). PMC: 6801789. DOI: 10.3390/ijms20194720. View

Tang D, Chen Y, Fu G, Yuan T, Huang W, Wang Z . EpCAM inhibits differentiation of human liver progenitor cells into hepatocytes in vitro by activating Notch1 signaling. Biochem Biophys Res Commun. 2020; . DOI: 10.1016/j.bbrc.2020.02.041. View

Zhang H, Lu Y, Zhang Y, Dong J, Jiang S, Tang Y . DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis. Int Immunopharmacol. 2024; 140:112895. DOI: 10.1016/j.intimp.2024.112895. View

Guerrache A, Micheau O . TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling. Cells. 2024; 13(6. PMC: 10968836. DOI: 10.3390/cells13060521. View

10.

Ghafouri-Fard S, Hajiesmaeili M, Shoorei H, Bahroudi Z, Taheri M, Sharifi G . The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer. Front Cell Dev Biol. 2021; 9:696820. PMC: 8339916. DOI: 10.3389/fcell.2021.696820. View

11.

Durinck S, Spellman P, Birney E, Huber W . Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009; 4(8):1184-91. PMC: 3159387. DOI: 10.1038/nprot.2009.97. View

12.

Zhang S, Wang Y, Jia L, Wen X, Du Z, Wang C . Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing. Genome Res. 2019; 29(9):1521-1532. PMC: 6724666. DOI: 10.1101/gr.244996.118. View

13.

Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

14.

Chen Y, Yang W, Shi X, Zhang C, Song G, Huang D . The Factors and Pathways Regulating the Activation of Mammalian Primordial Follicles . Front Cell Dev Biol. 2020; 8:575706. PMC: 7554314. DOI: 10.3389/fcell.2020.575706. View

15.

Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson R . Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019; 25(6):673-693. PMC: 6847836. DOI: 10.1093/humupd/dmz027. View

16.

Cuomo D, Porreca I, Ceccarelli M, Threadgill D, Barrington W, Petriella A . Transcriptional landscape of mouse-aged ovaries reveals a unique set of non-coding RNAs associated with physiological and environmental ovarian dysfunctions. Cell Death Discov. 2018; 4:112. PMC: 6281605. DOI: 10.1038/s41420-018-0121-y. View

17.

Piasecka-Srader J, Blanco F, Delman D, Dixon D, Geiser J, Ciereszko R . Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biol Reprod. 2015; 92(5):132. PMC: 4645984. DOI: 10.1095/biolreprod.114.126136. View

18.

Gil N, Ulitsky I . Production of Spliced Long Noncoding RNAs Specifies Regions with Increased Enhancer Activity. Cell Syst. 2018; 7(5):537-547.e3. PMC: 6542670. DOI: 10.1016/j.cels.2018.10.009. View

19.

van der Gun B, Melchers L, Ruiters M, de Leij L, McLaughlin P, Rots M . EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis. 2010; 31(11):1913-21. DOI: 10.1093/carcin/bgq187. View

20.

Luan Y, Edmonds M, Woodruff T, Kim S . Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol. 2018; 240(2):243-256. PMC: 6540791. DOI: 10.1530/JOE-18-0370. View